메뉴 건너뛰기




Volumn 25, Issue , 2016, Pages S27-S33

Bacteriophage treatment of intransigent Diabetic toe ulcers: A case series

Author keywords

Amputation; Bacteriophage; Diabetic foot ulcer; Osteomyelitis; Phage therapy

Indexed keywords


EID: 84978374640     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2016.25.7.S27     Document Type: Article
Times cited : (165)

References (31)
  • 1
    • 84864383895 scopus 로고    scopus 로고
    • Diabetic foot infections: Current concept review
    • Hobizal, K. B., Wukich, D. K. Diabetic foot infections: current concept review. Diabet Foot Ankle 2012;3; doi: 10.3402/dfa.v3i0.18409
    • (2012) Diabet Foot Ankle , vol.3
    • Hobizal, K.B.1    Wukich, D.K.2
  • 2
    • 78651091303 scopus 로고    scopus 로고
    • Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation
    • Van Battum, P., Schaper, N., Prompers, L., et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011;28:2, 199-205.
    • (2011) Diabet Med , vol.28 , Issue.2 , pp. 199-205
    • Van Battum, P.1    Schaper, N.2    Prompers, L.3
  • 3
    • 84862736689 scopus 로고    scopus 로고
    • A molecular and culture-based assessment of the microbial diversity of the diabetic chronic foot wounds and contralateral skin sites
    • Oates, A., Bowling, F. L., Boulton, A. J., McBain, A. J. A molecular and culture-based assessment of the microbial diversity of the diabetic chronic foot wounds and contralateral skin sites. J Clin Microbiol 2012;50:7, 2263-2271.
    • (2012) J Clin Microbiol , vol.50 , Issue.7 , pp. 2263-2271
    • Oates, A.1    Bowling, F.L.2    Boulton, A.J.3    McBain, A.J.4
  • 4
    • 77956596380 scopus 로고    scopus 로고
    • Methicillin-resistant Staphylococcus aureus in diabetic foot infections
    • Eleftheriadou, I., Tentolouris, N., Argiana, V. et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010;70:14, 1785-1797.
    • (2010) Drugs , vol.70 , Issue.14 , pp. 1785-1797
    • Eleftheriadou, I.1    Tentolouris, N.2    Argiana, V.3
  • 5
    • 84896722470 scopus 로고    scopus 로고
    • Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: A randomized comparative trial
    • Lázaro-Martínez, J. L., Aragón-Sánchez, J., García-Morales, E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care 2014;37:3, 789-795.
    • (2014) Diabetes Care , vol.37 , Issue.3 , pp. 789-795
    • Lázaro-Martínez, J.L.1    Aragón-Sánchez, J.2    García-Morales, E.3
  • 6
    • 84896722470 scopus 로고    scopus 로고
    • Antibiotics vs conservative surgery for treating diabetic foot osteomyelitis. A randomized comparitive trial
    • Lázaro-Martinez, J. L., Aragon-Sanchez, J., García-Morales, E. Antibiotics vs conservative surgery for treating diabetic foot osteomyelitis. a randomized comparitive trial. Diabetes Care 2014;37:3, 789-795.
    • (2014) Diabetes Care , vol.37 , Issue.3 , pp. 789-795
    • Lázaro-Martinez, J.L.1    Aragon-Sanchez, J.2    García-Morales, E.3
  • 7
    • 0041308236 scopus 로고    scopus 로고
    • Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology
    • Moulik, P. K., Mtonga, R., Gill, G. V. Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology. Diabetes Care 2003;26:2, 491-494
    • (2003) Diabetes Care , vol.26 , Issue.2 , pp. 491-494
    • Moulik, P.K.1    Mtonga, R.2    Gill, G.V.3
  • 8
    • 84860389517 scopus 로고    scopus 로고
    • Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens
    • Kvachadze, L., Balarjishvili, N., Meskhi, T., et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Micro biotechnol 2011;4:5, 643-650.
    • (2011) Micro Biotechnol , vol.4 , Issue.5 , pp. 643-650
    • Kvachadze, L.1    Balarjishvili, N.2    Meskhi, T.3
  • 11
    • 84873280551 scopus 로고    scopus 로고
    • Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: A new approach to chronic wound care
    • Seth, A. K., Geringer, M. R., Nguyen, K. T. et al. Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast Reconstr Surg 2013;131:2, 225-234.
    • (2013) Plast Reconstr Surg , vol.131 , Issue.2 , pp. 225-234
    • Seth, A.K.1    Geringer, M.R.2    Nguyen, K.T.3
  • 12
    • 84862903848 scopus 로고    scopus 로고
    • Genomics of staphylocollal Twort-like phages - Potential therapeutics of the post-antibiotic era
    • Lobocka, M., Hejnowicz, M., Dabrowski, K. et. al. Genomics of staphylocollal Twort-like phages - potential therapeutics of the post-antibiotic era. Adv Virus Res 2012;83:143-216.
    • (2012) Adv Virus Res , vol.83 , pp. 143-216
    • Lobocka, M.1    Hejnowicz, M.2    Dabrowski, K.3
  • 14
    • 84878321621 scopus 로고    scopus 로고
    • Phage cocktails and the future of phage therapy
    • Chan, B. K., Abedon, S. T., Loc-Carrillo, C. Phage Cocktails and the Future of Phage Therapy. Future Microbiol 2013;8:6, 769-783.
    • (2013) Future Microbiol , vol.8 , Issue.6 , pp. 769-783
    • Chan, B.K.1    Abedon, S.T.2    Loc-Carrillo, C.3
  • 15
    • 77950166515 scopus 로고    scopus 로고
    • Phage therapy in clinical practice: Treatment of human infections
    • Kutter, E., De Vos, D., Gvasalia, G. et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 2010;11:1, 69-86.
    • (2010) Curr Pharm Biotechnol , vol.11 , Issue.1 , pp. 69-86
    • Kutter, E.1    De Vos, D.2    Gvasalia, G.3
  • 16
    • 70349775117 scopus 로고    scopus 로고
    • Bacteriophage therapy of venous leg ulcers in humans; Results of a phase I safety trial
    • Rhoads, D. D., Wolcott, R. D., Kuskowski M. A. et. al. Bacteriophage therapy of venous leg ulcers in humans; Results of a phase I safety trial. J Wound Care 2009;18:6, 237-243.
    • (2009) J Wound Care , vol.18 , Issue.6 , pp. 237-243
    • Rhoads, D.D.1    Wolcott, R.D.2    Kuskowski, M.A.3
  • 17
    • 64049105821 scopus 로고    scopus 로고
    • Quality-Controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials
    • Merabishvili, M., Pirnay, J-P., Verbeken, G., et al. Quality-Controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS one 2009;4:3, e4944.
    • (2009) PLoS One , vol.4 , Issue.3 , pp. e4944
    • Merabishvili, M.1    Pirnay, J.-P.2    Verbeken, G.3
  • 18
    • 77950166515 scopus 로고    scopus 로고
    • Phage therapy in clinical practice: Treatment of human infections
    • Kutter, E., De Vos, D., Gvasalia, G. et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 2010;11:1, 69-86.
    • (2010) Curr Pharm Biotechnol , vol.11 , Issue.1 , pp. 69-86
    • Kutter, E.1    De Vos, D.2    Gvasalia, G.3
  • 19
    • 85047104395 scopus 로고    scopus 로고
    • Experimental phage therapy of burn wound infection: Difficult first steps
    • Rose, T., Verbeken, G., DeVos, D. et al. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burn Trauma 2014;4:2, 66-73.
    • (2014) Int J Burn Trauma , vol.4 , Issue.2 , pp. 66-73
    • Rose, T.1    Verbeken, G.2    DeVos, D.3
  • 20
    • 84904060123 scopus 로고    scopus 로고
    • Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool
    • Kažmierczak, Z., Górski, A., Dabrowska, K. Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses 2014;6:7, 2551-2570.
    • (2014) Viruses , vol.6 , Issue.7 , pp. 2551-2570
    • Kažmierczak, Z.1    Górski, A.2    Dabrowska, K.3
  • 22
    • 84978384938 scopus 로고    scopus 로고
    • Bacteriophage therapy of Staphylococcus aureus including MRSA
    • accessed 20 June 2016
    • Kuhl, S., Kearney, G. Bacteriophage therapy of Staphylococcus aureus including MRSA. Infectious Disease Society of America meeting poster. 2011. Available at: http://bit.ly/28JcpCa (accessed 20 June 2016)
    • (2011) Infectious Disease Society of America Meeting Poster
    • Kuhl, S.1    Kearney, G.2
  • 23
    • 0005592461 scopus 로고
    • Staphylococcus bacteriophage lysate topical and parenteral use in allergic patients
    • Baker, A. G. Staphylococcus bacteriophage lysate topical and parenteral use in allergic patients. Pa Med J 1963;66:25-28.
    • (1963) Pa Med J , vol.66 , pp. 25-28
    • Baker, A.G.1
  • 24
    • 0005551398 scopus 로고
    • Staphage Lysate Therapy in chronic staphylococcal infections
    • Salmon, G. G., Symonds, M. Staphage Lysate Therapy in chronic staphylococcal infections. J Med Soc N J 1963;60:188-193.
    • (1963) J Med Soc N J , vol.60 , pp. 188-193
    • Salmon, G.G.1    Symonds, M.2
  • 25
    • 0023623943 scopus 로고
    • Beneficial effect of Staphage Lysate in the treatment of chronic recurring Hidradenitis suppurativa
    • Angel, M. F., Ramasastry, S. S. Manders, E. K. et al Beneficial effect of Staphage Lysate in the treatment of chronic recurring Hidradenitis suppurativa. Surg Forum 1987;38:111.
    • (1987) Surg Forum , vol.38 , pp. 111
    • Angel, M.F.1    Ramasastry, S.S.2    Manders, E.K.3
  • 26
    • 68349154135 scopus 로고    scopus 로고
    • A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
    • Wright, A., Hawkins, C. H., Anggard, E. E., Harper, D. R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 2009;34:4, 349-357.
    • (2009) Clin Otolaryngol , vol.34 , Issue.4 , pp. 349-357
    • Wright, A.1    Hawkins, C.H.2    Anggard, E.E.3    Harper, D.R.4
  • 27
    • 84978398725 scopus 로고    scopus 로고
    • Evaluation of phage therapy for the treatment of Escherichia coli and pseudomonas aeruginosa wound infections in burned patients (PHAGOBURN)
    • accessed 15 June 2016
    • Pherecydes Pharma. Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (PHAGOBURN). In: ClinicalTrials.gov. Available at: http://1.usa.gov/1YtJ43U (accessed 15 June 2016).
    • ClinicalTrials.gov
    • Pherecydes Pharma1
  • 28
    • 84861510108 scopus 로고    scopus 로고
    • 2012; Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections
    • Lipsky, B. A., Berendt, A. R., Cornia, P. B. et al. 2012; Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:12, e132-e173.
    • (2012) Clin Infect Dis , vol.54 , Issue.12 , pp. e132-e173
    • Lipsky, B.A.1    Berendt, A.R.2    Cornia, P.B.3
  • 29
    • 84927941077 scopus 로고    scopus 로고
    • accessed 20 June 2016
    • Centre Watch. FDA Approved Drugs. Available at: http://bit.ly/28IXZVm (accessed 20 June 2016).
    • FDA Approved Drugs
    • Centre Watch1
  • 30
    • 84870672465 scopus 로고    scopus 로고
    • What is needed for phage therapy to become a reality in Western medicine?
    • Brüssow, H. What is needed for phage therapy to become a reality in Western medicine? Virology 2012;434:2, 138-142.
    • (2012) Virology , vol.434 , Issue.2 , pp. 138-142
    • Brüssow, H.1
  • 31
    • 84924338387 scopus 로고    scopus 로고
    • Microbiology of diabetic foot infection: From Louis Pasteur to 'crime scene investigation'
    • Spichler, A., Hurwitz, B. L., Armstrong, D. G., Lipsky, B. A. Microbiology of diabetic foot infection: from Louis Pasteur to 'crime scene investigation'. BMC Medicine 2015;13:2.
    • (2015) BMC Medicine , vol.13 , pp. 2
    • Spichler, A.1    Hurwitz, B.L.2    Armstrong, D.G.3    Lipsky, B.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.